Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
about
Argatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives.Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.Update on the clinical applications of argatroban.Pharmacology of argatroban.The Pharmacotherapy of Heparin-Induced Thrombocytopenia (HIT) : A Review of Contemporary Therapeutic Challenges in Clinical Practice.Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban.
P2860
Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Treatment of patients with a h ...... in antibodies with argatroban.
@ast
Treatment of patients with a h ...... in antibodies with argatroban.
@en
type
label
Treatment of patients with a h ...... in antibodies with argatroban.
@ast
Treatment of patients with a h ...... in antibodies with argatroban.
@en
prefLabel
Treatment of patients with a h ...... in antibodies with argatroban.
@ast
Treatment of patients with a h ...... in antibodies with argatroban.
@en
P2093
P2860
P1476
Treatment of patients with a h ...... in antibodies with argatroban.
@en
P2093
Ingrid Jörg
Lukas Piazolo
Tivadar Fenyvesi
P2860
P2888
P356
10.1007/S11239-005-0942-4
P577
2005-02-01T00:00:00Z